Skip to main content
  • Book
  • © 2003

DNA Topoisomerases in Cancer Therapy

Present and Future

Editors:

  • Commemorates the 30th anniversary of the discovery in 1971 of the first DNA topoisomerases, i.e topoisomerase I in E. coli

  • Pioneer Jim Wang at Harvard University, contributed an article: `Reflections on an accidental discovery' of the enzyme

Buy it now

Buying options

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (9 chapters)

  1. Front Matter

    Pages i-xii
  2. Reflections on an accidental discovery

    • James C. Wang
    Pages 1-13
  3. Mechanisms of topoisomerase I inhibition by anticancer drugs

    • Yves Pommier, Juana Barceló, Takahisa Furuta, Haruyuki Takemura, Olivier Sordet
    Pages 15-52
  4. Mechanism of action of topoisomerase II-targeted anticancer drugs

    • Kenneth D. Bromberg, Neil Osheroff
    Pages 53-78
  5. Yeast as a model system in the analysis of DNA topoisomerase I poisons

    • Hervé R. Jacquiau, Mary-Ann Bjornsti
    Pages 89-107
  6. Cellular resistance to DNA Topoisomerase I-targeting drugs

    • Kae Yanase, Toshiwo Andoh
    Pages 129-143
  7. Development of new topoisomerase I-targeting compounds as candidate anticancer drugs

    • Yves Pommier, ZhiYong Liao, LingHua Meng
    Pages 145-165
  8. Development of new topoisomerase II-targeting compounds as candidate anticancer drugs

    • Toshiwo Andoh, Ken Umemura, Kae Yanase, Takao Yamori
    Pages 167-188
  9. Back Matter

    Pages 189-202

About this book

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

Editors and Affiliations

  • Department of Bioengineering Faculty of Engineering, Soka University, Hachioji, Tokyo, Japan

    Toshiwo Andoh

Bibliographic Information

  • Book Title: DNA Topoisomerases in Cancer Therapy

  • Book Subtitle: Present and Future

  • Editors: Toshiwo Andoh

  • DOI: https://doi.org/10.1007/978-1-4615-0141-1

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2003

  • Hardcover ISBN: 978-0-306-47744-7Published: 30 June 2003

  • Softcover ISBN: 978-1-4613-4941-9Published: 23 October 2012

  • eBook ISBN: 978-1-4615-0141-1Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XII, 202

  • Topics: Biochemistry, general, Oncology, Medical Biochemistry

Buy it now

Buying options

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access